Authors
Latest:
Emerging Opportunity in GuatemalaGuatemala is multi-ethnic, multilingual, and multi-cultural-ideal for international trials.
Latest:
PK in Late Phase TrialsCollecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.
Latest:
My 3 Key Reflections on Partnerships in Clinical Trials USA 2016Technology advancement has been breaking down traditional barriers and has provided an answer to how the industry can move forward. The Partnerships in Clinical Trials Conference in Boston drove home this approach with three key themes that were present at the event.
Latest:
Electronic Endpoint AdjudicationHow an integrated, EDC-based system can optimize the endpoint process.
Latest:
Rethinking Document SharingThe benefits of peer-to-peer networking over email, fax, FTP, and hosted solutions.
Latest:
Beware of Costly ConsequencesNoncompliance with the US Foreign Corrupt Practices Act carries heavy penalties.
Latest:
Reducing Risk Through Mitigation StrategiesProactive risk management helps pharma protect their product development investments and future.
Latest:
Reducing Risk Through Mitigation StrategiesProactive risk management helps pharma protect their product development investments and future.
Latest:
Oh No Not Again...Investigator training should not be a "one-off" session at the start of clinical trial.
Latest:
Triggered MonitoringAmong the many clinical development processes that need to be conducted in a smarter, more cost-effective manner, clinical data monitoring stands out as a promising area in which operational efficiencies can not only reduce costs but also improve research quality and patient safety.
Latest:
Information as a Strategic AssetUses for next generation information management, called health intelligence, in research.
Latest:
The Future of Patient Engagement: Applying What We Know NowWhile patient centricity has been a newfound goal of the pharma industry, many would argue that adopting this philosophy has been more talk than action thus far. eClinicalHealth conducted a case study to learn what patient engagement means to industry professionals.
Latest:
Information as a Strategic AssetUses for next generation information management, called health intelligence, in research.
Latest:
Information in Action: DIA's Barbara Lopez KunzWilliam Looney speaks with DIA's Global Chief Executive to see how the organization is repositioning itself.
Latest:
Beware of Costly ConsequencesNoncompliance with the US Foreign Corrupt Practices Act carries heavy penalties.
Latest:
Trials in Latin AmericaAn overview of the clinical research landscape in this emerging region that also looks at its challenges.
Latest:
Reducing the Data Burden for Clinical InvestigatorsClinical trials have changed significantly in the past decade with increasingly large and complex global studies. Multi-center, multinational trials are common, with complicated treatment protocols, large staffs, and huge data sets muddling the clinical trial processes. With years of development time and millions in R&D invested in a new treatment before it reaches the trial stage, there is incredible pressure on investigators to deliver quality data.
Latest:
Enabling Digital Transformation: Managing External Clinical Data Sources to Advance Drug DevelopmentWith an increasing amount of diverse data that must now be collected and analyzed, the industry is faced with increasingly complex studies that present new challenges in data management.
Latest:
Sunshine Act's ImpactThe amendment addresses data concerns for both physicians and drug/device manufacturers.
Latest:
Triggered MonitoringAmong the many clinical development processes that need to be conducted in a smarter, more cost-effective manner, clinical data monitoring stands out as a promising area in which operational efficiencies can not only reduce costs but also improve research quality and patient safety.
Latest:
Information as a Strategic AssetUses for next generation information management, called health intelligence, in research.
Latest:
Imaging CROs in AsiaImprovements in image acquisition and read quality: A look at the value of standardization in oncology trials.
Latest:
Simplicity is the Ultimate SophisticationHow one eClinical platform can create unparalleled efficiency in the future.
Latest:
Trials in Latin AmericaAn overview of the clinical research landscape in this emerging region that also looks at its challenges.
